Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : RWTH Aachen University, represented by the Rector, himself represented by Clinical Trial Center (CTC-A)

Homme Max 99 ans
RWTH Aachen University, represented by the Rector, himself represented by Clinical Trial Center (CTC-A) MAJ Il y a 4 ans

Neoadjuvant chemotherapy with Cabazitaxel in high risk prostate cancer patients prior to radical prostatectomy Neoadjuvante Chemotherapie mit Cabazitaxel vor der radikalen Prostatektomie The primary goal of this trial is to define the pathologic complete response rate of cabazitaxel chemotherapy in patients with untreated, high-risk localized prostate cancer.

Pays Aucun
Organes Aucun
Spécialités Aucune

unknown

Plus d'informations